Medical NewsJnJ discontinues mid stage study of skin disease drug DRRA3 days ago01 mins JnJ discontinues mid stage study of skin disease drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link Post navigation Previous: Medical Bulletin 27/December/2025Next: Spot Symptoms, Prevent Respiratory Infection, and Manage Cough & Fever Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.